Authors:
ROBERTS JC
PHANEUF HL
SZAKACS JG
ZERA RT
LAMB JG
FRANKLIN MR
Citation: Jc. Roberts et al., DIFFERENTIAL CHEMOPROTECTION AGAINST ACETAMINOPHEN-INDUCED HEPATOTOXICITY BY LATENTIATED L-CYSTEINES, Chemical research in toxicology, 11(11), 1998, pp. 1274-1282
Citation: M. Vargas et al., PHASE II-SELECTIVE INDUCTION OF HEPATIC DRUG-METABOLIZING-ENZYMES BY OLTIPRAZ [5-(2-PYRAZINYL)-4-METHYL-1,2-DITHIOL-3-THIONE], 1,7-PHENANTHROLINE, AND 2,2'-DYPYRIDYL IN RATS IS NOT ACCOMPANIED BY INDUCTION OF INTESTINAL ENZYMES, Drug metabolism and disposition, 26(2), 1998, pp. 91-97
Citation: Ba. Carr et Mr. Franklin, DRUG-METABOLIZING ENZYME-INDUCTION BY 2,2'-DIPYRIDYL, 1,7-PHENANTHROLINE, 7,8-BENZOQUINOLINE AND OLTIPRAZ IN MOUSE, Xenobiotica (London. Print), 28(10), 1998, pp. 949-956
Citation: Mr. Franklin et al., CYTOCHROME-P450 INDUCTION, UROPORPHYRINOGEN DECARBOXYLASE DEPRESSION,PORPHYRIN ACCUMULATION AND EXCRETION, AND GENDER INFLUENCE IN A 3-WEEK RAT MODEL OF PORPHYRIA-CUTANEA-TARDA, Toxicology and applied pharmacology, 147(2), 1997, pp. 289-299
Citation: Ht. Le et Mr. Franklin, SELECTIVE INDUCTION OF PHASE-II DRUG-METABOLIZING ENZYME-ACTIVITIES BY QUINOLINES AND ISOQUINOLINES, Chemico-biological interactions, 103(3), 1997, pp. 167-178
Citation: Mh. Slawson et al., CORRELATIONS OF THE INDUCTION OF MICROSOMAL EPOXIDE HYDROLASE ACTIVITY WITH PHASE-II DRUG CONJUGATING ENZYME-ACTIVITIES IN RAT-LIVER, Toxicology letters, 85(1), 1996, pp. 29-34
Authors:
FERNANDES HM
FRANKLIN MR
VEIGA LHS
FREITAS P
GOMIERO LA
Citation: Hm. Fernandes et al., MANAGEMENT OF URANIUM MILL TAILING - GEOCHEMICAL PROCESSES AND RADIOLOGICAL RISK ASSESSMENT, Journal of environmental radioactivity, 30(1), 1996, pp. 69-95
Authors:
WYCKOFF EE
PHILLIPS JD
SOWA AM
FRANKLIN MR
KUSHNER JP
Citation: Ee. Wyckoff et al., MUTATIONAL ANALYSIS OF HUMAN UROPORPHYRINOGEN DECARBOXYLASE, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1298(2), 1996, pp. 294-304
Citation: Rb. Raftogianis et al., EFFECT OF TOTAL PARENTERAL-NUTRITION CONTAINING LIPID CALORIES ON HEPATIC DRUG-METABOLISM IN RATS, Drug metabolism and disposition, 24(4), 1996, pp. 502-505
Citation: Rb. Raftogianis et al., EFFECT OF LIPID-FREE TOTAL PARENTERAL-NUTRITION ON HEPATIC DRUG CONJUGATION IN RATS, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 602-608
Citation: Hm. Fernandes et al., ENVIRONMENTAL-IMPACT ASSESSMENT OF URANIUM MINING AND MILLING FACILITIES - A STUDY CASE AT THE POCOS-DE-CALDAS URANIUM MINING AND MILLING SITE, BRAZIL, Journal of geochemical exploration, 52(1-2), 1995, pp. 161-173
Citation: Rb. Raftogianis et al., THE DEPRESSION OF HEPATIC DRUG CONJUGATION REACTIONS IN RATS AFTER LIPID-FREE TOTAL PARENTERAL-NUTRITION ADMINISTERED VIA THE PORTAL-VEIN, JPEN. Journal of parenteral and enteral nutrition, 19(4), 1995, pp. 303-309
Citation: Mr. Franklin, ENHANCED RATES OF CYTOCHROME-P450 METABOLIC-INTERMEDIATE COMPLEX-FORMATION FROM NONMACROLIDE AMINES IN RIFAMPICIN-TREATED RABBIT LIVER-MICROSOMES, Drug metabolism and disposition, 23(12), 1995, pp. 1379-1382
Citation: Mr. Franklin et Jc. Roberts, THE RELATIVE ABILITY OF BSO AND OTHER GAMMA-GLUTAMYLCYSTEINE SYNTHETASE INHIBITORS TO BOTH DEPLETE GLUTATHIONE AND ALTER DRUG-METABOLIZING ENZYME-ACTIVITIES, Bioorganic & medicinal chemistry letters, 4(7), 1994, pp. 935-940
Citation: Mr. Franklin et al., UGT2C1 - THE 1ST OF A NEW SUBFAMILY OF UDP-GLUCURONOSYLTRANSFERASES IDENTIFIED FROM A RABBIT LIVER CDNA LIBRARY, The FASEB journal, 7(7), 1993, pp. 1202-1202
Citation: Jb. Pappas et Mr. Franklin, HEPATIC CLOTRIMAZOLE CONCENTRATIONS AND HEPATIC DRUG-METABOLIZING ENZYME-ACTIVITIES IN ADULT MALE SPRAGUE-DAWLEY RATS, Toxicology, 80(1), 1993, pp. 27-35
Citation: Mr. Franklin et al., SELECTIVE INDUCTION OF RAT-LIVER PHASE-II ENZYMES BY N-HETEROCYCLE ANALOGS OF PHENANTHRENE - A RESPONSE EXHIBITING HIGH CORRELATION BETWEENUDP-GLUCURONOSYLTRANSFERASE AND MICROSOMAL EPOXIDE HYDROLASE ACTIVITIES, Xenobiotica, 23(3), 1993, pp. 267-277
Citation: Mr. Franklin, INDUCTION OF RAT-LIVER DRUG-METABOLIZING-ENZYMES BY HETEROCYCLE-CONTAINING MONO-ARYLMETHANES, DI-ARYLMETHANES, TRI-ARYLMETHANES AND TETRA-ARYLMETHANES, Biochemical pharmacology, 46(4), 1993, pp. 683-689